Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We advised Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
Banco Santander $2.8 billion notes offering
We advised Banco Santander on the offering
Grupo Aeroméxico $275 million IPO
The shares are listed on the NYSE and the Bolsa Mexicana de Valores
Dunkin’ 2025-1 $900 million whole business securitization offering
We advised the initial purchasers on the offering
Sycamore Partners $490 million CMBS refinancing of 207 Walgreens locations
We advised Sycamore Partners on the refinancing
BETA Technologies $1 billion IPO
The shares are listed on the New York Stock Exchange
Bloom Energy $2.5 billion convertible senior notes offering
The 0% convertible senior notes are due 2030
Bank of America €2.75 billion senior notes offering
The investment-grade notes are due 2029 and 2031
Oculis Holding $110 million concurrent stock offerings
The shares are listed on the Nasdaq Global Market and the Nasdaq Iceland Main Market
Cybin $175 million registered direct offering
The common shares are dual-listed on the NYSE American and Cboe Canada
PPG Industries $700 million notes offering
The investment-grade notes are due 2031